Imaging modalities for primary diagnosis and staging of prostate cancer;Bildgebende verfahren bei primärdiagnose und staging des prostatakarzinoms

Urologe - Ausgabe A

Volumn 49, Issue 2, 2010, Pages 190-198

  Mueller Lisse, U G ^b   Miller, K ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

Detection; Diagnosis; Imaging modalities; Prostate cancer; Staging

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER STAGING; DIGITAL RECTAL EXAMINATION; EARLY DIAGNOSIS; HUMAN; IMAGE QUALITY; LYMPH NODE DISSECTION; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPH NODE; PRACTICE GUIDELINE; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT; S3 GUIDELINE; SENSITIVITY AND SPECIFICITY;

BONE NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; DIGITAL RECTAL EXAMINATION; DISEASE PROGRESSION; EARLY DIAGNOSIS; ENDOSONOGRAPHY; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 77952635832     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-010-2235-6     Document Type: Review

References (43)

1. 1. Abuzallouf S, Dayes I, Lukka H (2004) Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol 171:2122-2127 (Pubitemid 38625418)
2. American Joint Committee on Cancer (AJCC) (2002) Cancer staging manual, 6th edn. Springer, Berlin Heidelberg New York
3. Amsellem-Ouazana D.Younes P, Conquy S et al (2005) Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur Urol 47:582-586
4. Bhatia C, Phongkitkarun S, Booranapitaksontl D et al (2007) Diagnostic accuracy of MRI/MRSI for patients with persistently high PSA levels and negativeTRUSgulded biopsy results. J Med Assoc Thai (Chotmalhet thangphaet) 90:1391-1399 (Pubitemid 47414514)
5. 5. Boni RA, Hutter BE, Trinkler F et al (1996) Preoperative T-staging of prostatic carcinoma: endorectal magnetic resonance tomography compared with other imaging and clinical methods. Fortschr Rontgenstr 165:152158 (Pubitemid 26298062)
6. ChoiYJ, Kim JK, Kim N et al (2007) Functional MR imaging of prostate cancer. Radiographics 27:63-77
7. Dutch Urological Association (2007) Prostate cancer. Nation-wide guideline. Version 1.0. Dutch Urological Association, Maastricht
8. 8. Engelbrecht MR, Jager GJ, Laheij RJ et al (2002) Local staging of prostate cancer using magnetic resonance Imaging: a meta-analysis. Eur Radiol 12:2294-2302 (Pubitemid 36940327)
9. Even-SapirE et al (2006) The detection of bone metastases In patients with high-risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single-and multi-field-of-view SPECT, 18F-fluoride PET, and 18Ffluoride PET/CT. J Nucl Med 47:287-297
10. Foster LS.Jajodia P, Fournier G Jr et al (1993)The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy. J Urol 149:1024-1028
11. 11. Freedland SJ, Humphreys EB, Mangold LA et al (2005) Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294:433-439 (Pubitemid 41124175)
12. 12. Freedland SJ, Sutter ME, Dorey F, Aronson WJ (2003) Defining the ideal cutpo int for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen. Urology 61:365-369 (Pubitemid 36206534)
13. Graser A, Heuck A, Sommer B et al (2007) Per-sextant localization and staging of prostate cancer: correlation of imaging findings with whole-mount step section histopathology.Am J Roentgenol 188:84-90
14. Halpern EJ, Strup SE (2000) Using gray-scale and color and power doppler sonography to detect prostatic cancer. Am J Roentgenol 174:623-627
15. 15. Hara N, Okuizumi M, Koike H et al (2005) Dynamic contrast-enhanced magnetic resonance Imaging (DCE-MRI) Isa useful modality for the precise detection and staging of early prostate cancer. Prostate 62:140-147 (Pubitemid 40096780)
16. Heidenreich A, Aus G, Abbou CC et al (2007) EAU guidelines on prostate cancer. EAU, Arnhem
17. 17. HeijmlnkSW, Fütterer JJ, Hambrock T et al (2007) Prostate cancer: body-array versus endorectal coil MR Imaging at 3 T-comparison of image quality, localization, and staging performance. Radiology 244:184-195 (Pubitemid 46981973)
18. Heuck A, Scheidler J, Sommer B et al (2003) MR-Tomographie des Prostata karzinoms. Radiologe 43:464-473
19. 19. Hoogendam A, Buntinx F, Vet HC de (1999) The diagnostic value of digital rectal examination in primary care screening for prostate cancer: a meta-analysis. Fam Pract 16:621-626 (Pubitemid 30000182)
20. 20. Hricak H, Choyke PL, Eberhardt SC et al (2007) Imaging prostate cancer: a multidisclplinary perspective. Radiology 243:28-53 (Pubitemid 46579693)
21. Hsu CY et al (2006) Detection of clinical unilateral T3a prostate cancer-by digital rectal examination or transrectal ultrasonography? BJU lnt 98:982-985
22. 22. Kurhanewicz J, Vigneron DB, Hricak H et al (1996) Three-dimensional H-1 MR spectroscopic Imaging of the In situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology 198:795-805 (Pubitemid 26066301)
23. Langer DL, KwastTH van der, Evans AJ et al (2008) Intermixed normal tissue within prostate cancer: effect on MR Imaging measurements of apparent diffusion coefficient and T2 - sparse versus dense cancers. Radiology 249:900-908
24. 24. Lavoipierre AM et al (1998) Prostatic cancer: role of color doppler imaging in transrectal sonography. AJR Am J Roentgenol 171:205-210 (Pubitemid 28308676)
25. 25. Maßmann J, Funk A, Altwein J, Praetorlus M (2003) Prostatakarzlnom (PC) - eine organspezifische Neoplasie aus Sicht der Pathologie. Radiologe 43:423-431 (Pubitemid 36841588)
26. 26. Mueller-Lisse U, Mueller-Lisse U, Scheidler J et al (2005) Reproducibility of Image interpretation in MRI of the prostate: application of the sextant framework by two different radiologists. Eur Radiol 15:1826-1833 (Pubitemid 41222888)
27. Mueller-Lisse UG, Mueller-Lisse UL(2006) Männliches Becken - Prostata und Samenblasen. In: Rummeny EJ, Reimer P, Heindel W (Hrsg) Ganzkörper-MR-Tomographie. 2., vollst. Überarb. und erg. Aufl. Referenz-Reihe Radiologie (Modder U, Reihenherausgeber). Thieme, Stuttgart New York, S 390-401
28. Müller-Lisse UG, Scherr M (2003) 1 H-MR-Spektroskopie der Prostata: Ein Überblick. Radiologe 43:481-488
29. NICE, National Collaborating Centre for Cancer, National Institute for Health and Clinical Excellence (NICE) (2008) Prostate Cancer: diagnosis and treatment, (cited: 2009 Juli 01), Available from: http://www.nlce. org.uk/Guldance/CG58
30. Philip J et al (2005) Is a digital rectal examination necessary In the diagnosis and clinical staging of early prostate cancer? BJU lnt 95:969-971
31. 31. Prando A, Kurhanewlcz J, Borges AP et al (2005) Prostatic biopsy directed with endorectal MR spectroscopic Imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 236:903-910 (Pubitemid 41170854)
32. Roach M 3rd, Hanks GJhames H Jr et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO phoenix consensus conference, lnt J Radiat Oncol Biol Phys 65:965-974
33. 33. Scheldler J, Hrlcak H, Vigneron DB et al (1999) Prostate cancer: localization with three-dimensional proton MR spectroscopic Imaging- clinicopathologlc study. Radiology 213:473-480 (Pubitemid 29510595)
34. 34. Seitz M, Scher B, Scherr M et al (2007) Bildgebende Verfahren bel der Diagnose des Prostatakarzlnoms. Urologe A 46:1435-1446 (Pubitemid 350045866)
35. Smith JA Jr et al (1997)Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial. J Urol 157:902-906
36. Sonnad SS, Langlotz CP, Schwartz JS (2001 ) Accuracy of MR imaging for staging prostate cancer: a metaanalysis to examine the effect of technologic change. Acad Radiol 8:149-157
37. Stephenson AJ, Kattan MW, Eastham JA et al (2006) Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol 24:3973-3978
38. 38. Thompson I, Thrasher JB, Aus G et al (2007) Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 177:2106-2131 (Pubitemid 46726449)
39. 39. Wang L, Hricak H, Kattan MW et al (2006) Prediction of organ-confined prostate cancer: Incremental value of MR imaging and MR spectroscopic Imaging to staging nomograms. Radiology 238:597-603 (Pubitemid 43134372)
40. 40. Wang L, Hrlcak H, Kattan MW et al (2006) Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer. AJR Am J Roentgenol 186:743-748 (Pubitemid 46100258)
41. 41. Wang L, Hricak H, Kattan MW et al (2007) Prediction of seminal vesicle Invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram. Radiology 242:182-188 (Pubitemid 44956023)
42. Wittekind C, Mezer HJ, Bootz F (Hrsg) (2002) UICC-International Union against Cancer:TNM-Klassiflkation maligner Tumoren, 6. Aufl. Springer, Heidelberg Berlin, S 295
43. Yuen JS et al (2004) Endorectal magnetic resonance Imaging and spectroscopyforthe detection of tumor foci In men with prior negative transrectal ultrasound prostate biopsy.J Urol 171:1482-1486